FTT Logo
Editorial standard: How we test and compare

FDA Approves Eli Lilly’s Foundayo, a New Oral GLP-1 Weight Loss Pill

Marty S.

·

·

🔬 Health & Fitness Research

Foundayo’s approval signals what’s already happening in the wearable market: GLP-1 users are demanding better body composition tracking, recovery metrics, and metabolic insights—data that basic activity monitors can’t provide. The wearables racing to deliver these features will define the next market cycle.

Source: Forbes

Recovery Devices

More from Pulse

Samsung debuts AI-powered health assistant with new Galaxy Watch features
Aug 2
Garmin Launches Cirqa Band: $199 Recovery Tracker Challenges Whoop, Oura with Free Heart Rate Monitoring
Jul 30
Nothing’s First Smartwatch Coming September 2026 Under $300
Jul 29
Marty S.

Marty S.

Marty is a contributor at Fitness Tech Trends, focused on helping readers cut through the noise and make informed decisions about fitness technology. He dives deep into product comparisons, analyzes features that actually matter, and breaks down technical specs into practical insights. Whether readers are choosing between heart rate monitors, deciding on recovery tools, or figuring out which smartwatch fits their training style, Marty aims to provide straightforward, no-hype guidance. When he’s not researching the latest gear, he’s probably testing theories about what makes certain products stick while others fade into the gadget graveyard.